Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

243

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

April 30, 2017

Conditions
Venous Thromboembolism
Interventions
DRUG

Sodium enoxaparin

40 mg/mL

DRUG

Sodium Enoxaparin clexane

clexane 40 mg/ 0,4 mL

Trial Locations (9)

Unknown

Hospital Regional da Asa Norte, Brasília

92425-900

Huning Instituto de Oftalmologia e Pesquisa HIOP/HRPC, Canoas

90035-903

Hospital de Clínicas de Porto Alegre, Porto Alegre

90610-000

Hospital São Lucas da PUCRS, Porto Alegre

13083-970

Fundação de Desenvolvimento da Unicamp - FUNCAMP, Campinas

14015-130

Hospital das Clínicas de Riberião Preto, Ribeirão Preto

09190615

Hospital Estadual Mario Covas, Santo André

09780000

Centro Multidisciplinar de Estudos Clínicos, São Bernardo do Campo

15090-000

Fundação Faculdade Regional de Medicina de São José do Rio Preto, São Jósé Do Rio Preto

All Listed Sponsors
lead

Cristália Produtos Químicos Farmacêuticos Ltda.

INDUSTRY

NCT01308528 - Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery | Biotech Hunter | Biotech Hunter